Literature DB >> 16461597

What is the impact of change in diagnostic test method on surveillance data trends in Chlamydia trachomatis infection?

F Burckhardt1, P Warner, H Young.   

Abstract

OBJECTIVE: To describe the impact of change from culture to more sensitive nucleic acid amplification testing (NAAT) tests on the detection of Chlamydia trachomatis in a genitourinary medicine (GUM) clinic population.
METHODS: Data were collected between January 1992 and December 2003 on results of C trachomatis tests on male and female attenders at the Lothian GUM clinic (n = 81 590). Routine diagnosis switched from culture to NAAT methods in September 1998. Association of test result with age, sex, year of test, and test type was analysed using logistic regression.
RESULTS: 6.1% (95% CI: 5.7% to 6.5%) of women and 7.1% of men (95% CI: 6.7% to 7.5%) tested positive with culture and 9.9% of women (95% CI: 9.4% to 10.3%) and 11.1% of men (95% CI: 10.7% to 11.5%) tested positive with NAATs. This corresponds to a 56% increase for men (95% CI: 47% to 66%) and 62% for women (95% CI: 50% to 67%). Logistic regression showed that a positive test result was strongly associated with test type with or without adjustment for year of test, sex, and young age.
CONCLUSIONS: The significant increase in chlamydial infections detected following a change from culture to NAATs has important implications for interpretation of trends ascertained from surveillance data. Not all of this can be a direct effect of enhanced sensitivity and there may be indirect effects that improve ascertainment of existing infections. As more laboratories switch to NAATs similar patterns of stepwise increases in positive results are expected and trend analysis based on such surveillance data might thus show an artefactual rise in chlamydia infection rates. Accumulated surveillance data should therefore include timing of introduction of NAAT, so as to take account of under-ascertainment by previous methods.

Entities:  

Mesh:

Year:  2006        PMID: 16461597      PMCID: PMC2563817          DOI: 10.1136/sti.2004.011882

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  22 in total

1.  Empirical evidence of design-related bias in studies of diagnostic tests.

Authors:  J G Lijmer; B W Mol; S Heisterkamp; G J Bonsel; M H Prins; J H van der Meulen; P M Bossuyt
Journal:  JAMA       Date:  1999-09-15       Impact factor: 56.272

2.  National guideline for the management of Chlamydia trachomatis genital tract infection. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).

Authors: 
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

3.  Opportunistic screening for chlamydia infection in general practice: can we reach young women?

Authors:  M Santer; P Warner; S Wyke; S Sutherland
Journal:  J Med Screen       Date:  2000       Impact factor: 2.136

Review 4.  The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review.

Authors:  Emma J Watson; Allan Templeton; Ian Russell; Jorma Paavonen; Per-Anders Mardh; Angelika Stary; Babil Stray Pederson
Journal:  J Med Microbiol       Date:  2002-12       Impact factor: 2.472

5.  Use of ligase chain reaction for laboratory identification of Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent women.

Authors:  Paula K Braverman; Donald F Schwarz; Md Mph; Adamadia Deforest; Richard L Hodinka; Karin L McGowan; Joel E Mortensen
Journal:  J Pediatr Adolesc Gynecol       Date:  2002-02       Impact factor: 1.814

6.  Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection.

Authors:  K A Fenton; C Korovessis; A M Johnson; A McCadden; S McManus; K Wellings; C H Mercer; C Carder; A J Copas; K Nanchahal; W Macdowall; G Ridgway; J Field; B Erens
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

7.  Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours.

Authors:  A M Johnson; C H Mercer; B Erens; A J Copas; S McManus; K Wellings; K A Fenton; C Korovessis; W Macdowall; K Nanchahal; S Purdon; J Field
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

8.  The 'real-world' impact of improved diagnostic techniques for Chlamydia trachomatis infection in Glasgow.

Authors:  A Scoular; R McCartney; S Kinn; S Carr; A Walker
Journal:  Commun Dis Public Health       Date:  2001-09

9.  The accuracy of reported sensitive sexual behaviour in Britain: exploring the extent of change 1990-2000.

Authors:  A J Copas; K Wellings; B Erens; C H Mercer; S McManus; K A Fenton; C Korovessis; W Macdowall; K Nanchahal; A M Johnson
Journal:  Sex Transm Infect       Date:  2002-02       Impact factor: 3.519

10.  Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods?

Authors:  Hannelore Götz; Johan Lindback; Torvald Ripa; Malin Arneborn; Kristina Ramsted; Karl Ekdahl
Journal:  Scand J Infect Dis       Date:  2002
View more
  6 in total

Review 1.  Vaginal discharge.

Authors:  Des Spence; Catriona Melville
Journal:  BMJ       Date:  2007-12-01

2.  Chlamydia trachomatis Infection: Screening and Management.

Authors:  Mary B Keegan; Justin T Diedrich; Jeffrey F Peipert
Journal:  J Clin Outcomes Manag       Date:  2014-01

3.  The implementation of European Association of Urology guidelines in the management of acute epididymo-orchitis.

Authors:  Mary A E Garthwaite; G Johnson; S Lloyd; I Eardley
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

4.  Current crisis or artifact of surveillance: insights into rebound chlamydia rates from dynamic modelling.

Authors:  David M Vickers; Nathaniel D Osgood
Journal:  BMC Infect Dis       Date:  2010-03-16       Impact factor: 3.090

5.  How do changes in the population tested for chlamydia over time affect observed trends in chlamydia positivity? Analysis of routinely collected data from young women tested for chlamydia in family planning clinics in the Pacific Northwest (USA), between 2003 and 2010.

Authors:  Sarah C Woodhall; Lizzi Torrone; David Fine; Sarah G Salomon; Wendy Nakatsukasa-Ono; Kate Soldan; Hillard Weinstock
Journal:  Sex Health       Date:  2015-11       Impact factor: 2.706

6.  Increased incidence of gonorrhoea and chlamydia in Greenland 1990-2012.

Authors:  Mila Broby Johansen; Anders Koch; Jan Wohlfahrt; Mads Kamper-Jørgensen; Steen Hoffmann; Bolette Soborg
Journal:  Int J Circumpolar Health       Date:  2017       Impact factor: 1.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.